Dose-Escalating and Safety Study of CP-461 in Patients With Chronic Lymphocytic Leukemia
Clinical trial NCT00036257 · COMPLETED
Trial details
- NCT number
- NCT00036257
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2002-03-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.